For: | Wang YZ, Li JL, Wang X, Zhang T, Ho WZ. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. World J Gastroenterol 2017; 23(32): 5895-5903 [PMID: 28932081 DOI: 10.3748/wjg.v23.i32.5895] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i32/5895.htm |
Number | Citing Articles |
1 |
Jiaming Ge, Tianbao Song, Mengyuan Li, Weisan Chen, Jiarong Li, Sihan Gong, Ying Zhao, Lin Ma, Hongjian Yu, Xiankuan Li, Kun Fu. The medicinal value of tea drinking in the management of COVID-19. Heliyon 2023; 9(1): e12968 doi: 10.1016/j.heliyon.2023.e12968
|
2 |
Yan-Xi Zeng, Sen Wang, Lu Wei, Ying-Yu Cui, Yi-Han Chen. Proanthocyanidins: Components, Pharmacokinetics and Biomedical Properties. The American Journal of Chinese Medicine 2020; 48(04): 813 doi: 10.1142/S0192415X2050041X
|
3 |
Dongming Li, Donghui Cao, Yingnan Cui, Yuanlin Sun, Jing Jiang, Xueyuan Cao. The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201085
|
4 |
Naiara Naiana Dejani, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives. Biomolecules 2021; 11(8): 1254 doi: 10.3390/biom11081254
|